Most cited papers from Tumori Foundation

Tumori Foundation

What are the most cited papers from Tumori Foundation?

The most cited paper from Tumori Foundation is "Isolation and In vitro Propagation of Tumorigenic Breast Cancer Cells with Stem/Progenitor Cell Properties" (Dario Ponti, Aurora Costa, Nadia Zaffaroni et al., 2005), with 1,732 citations. Next come "Systematic Pelvic Lymphadenectomy vs No Lymphadenectomy in Early-Stage Endometrial Carcinoma: Randomized Clinical Trial" (1,570) and "ESTIMATING THE POPULATION ATTRIBUTABLE RISK FOR MULTIPLE RISK FACTORS USING CASE-CONTROL DATA" (1,256).

Published TypeFieldAccessCitations

Showing 50 of 60 papers. Every paper with more than 241 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Isolation and In vitro Propagation of Tumorigenic Breast Cancer Cells with Stem/Progenitor Cell Properties Dario Ponti, Aurora Costa, Nadia Zaffaroni et al. · Cancer Research Open access	Jul 2005	1,732
2	Systematic Pelvic Lymphadenectomy vs No Lymphadenectomy in Early-Stage Endometrial Carcinoma: Randomized Clinical Trial Pierluigi Benedetti Panici et al. · JNCI Journal of the National Cancer Institute	25 Nov 2008	1,570
3	ESTIMATING THE POPULATION ATTRIBUTABLE RISK FOR MULTIPLE RISK FACTORS USING CASE-CONTROL DATA Paolo Bruzzi, Sylvan B. Green, David P. Byar et al. · American Journal of Epidemiology	Nov 1985	1,256
4	Food-Based Validation of a Dietary Questionnaire: The Effects of Week-to-Week Variation in Food Consumption Simonetta Salvini, David J. Hunter, Laura Sampson et al. · International Journal of Epidemiology	1989	1,050
5	Induction of Lymphocyte Apoptosis by Tumor Cell Secretion of FasL-bearing Microvesicles Giovanna Andreola, Licia Rivoltini, Chiara Castelli et al. · The Journal of Experimental Medicine Open access	20 May 2002	770
6	Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study Agnès Fournier, Franco Berrino, Françoise Clavel‐Chapelon · Breast Cancer Research and Treatment Open access	27 Feb 2007	692
7	Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma Vincenzo Mazzaferro, Carlo Sposito, Jian Zhou et al. · Gastroenterology Open access	11 Oct 2017	656
8	Oral Contraceptives and the Risk of Hereditary Ovarian Cancer Steven Alexander Narod, Harvey A. Risch, Roxana Moslehi et al. · New England Journal of Medicine Open access	13 Aug 1998	622
9	A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms Philipp Harter et al. · New England Journal of Medicine Open access	27 Feb 2019	616
10	IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome Laura Belloni, Lena Allweiss, Francesca Guerrieri et al. · Journal of Clinical Investigation Open access	17 Jan 2012	579
11	Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor Salvatore Siena, Marco Bregni, Bruno Brando et al. · Blood	Nov 1989	536
12	Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy Ugo Pastorino, Mario Silva, Stefano Sestini et al. · Annals of Oncology Open access	29 Mar 2019	534
13	Collaborative Ocular Oncology Group Report Number 1: Prospective Validation of a Multi-Gene Prognostic Assay in Uveal Melanoma Michael D. Onken et al. · Ophthalmology Open access	21 Apr 2012	514
14	Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients Salvatore Siena, Marco Bregni, Bruno Brando et al. · Blood Open access	15 Jan 1991	512
15	IL-4-Induced Arginase 1 Suppresses Alloreactive T Cells in Tumor-Bearing Mice Vincenzo Bronte, Paolo Serafini, Carmela De Santo et al. · The Journal of Immunology Open access	2003	507
16	Radiofrequency Ablation of Small Hepatocellular Carcinoma in Cirrhotic Patients Awaiting Liver Transplantation Vincenzo Mazzaferro, Carlo Battiston, Stefano Perrone et al. · Annals of Surgery Open access	15 Oct 2004	491
17	Human Tumor-Released Microvesicles Promote the Differentiation of Myeloid Cells with Transforming Growth Factor-β–Mediated Suppressive Activity on T Lymphocytes Roberta Valenti, Veronica Huber, Paola Filipazzi et al. · Cancer Research Open access	15 Sep 2006	489
18	Comparing Adult and Pediatric Rhabdomyosarcoma in the Surveillance, Epidemiology and End Results Program, 1973 to 2005: An Analysis of 2,600 Patients Iyad Yasin Sultan, Ibrahim A. Qaddoumi, Sameer Yaser et al. · Journal of Clinical Oncology	27 Apr 2009	487
19	A listing of human tumor antigens recognized by T cells: March 2004 update Luisa Novellino, Chiara Castelli, Giorgio Parmiani · Cancer Immunology Immunotherapy Open access	6 Aug 2004	465
20	Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities Mario E. Lacouture, Milan J. Anadkat, René‐Jean Bensadoun et al. · Supportive Care in Cancer Open access	31 May 2011	446
21	Effect of Proton Pump Inhibitor Pretreatment on Resistance of Solid Tumors to Cytotoxic Drugs Francesca Luciani, Massimo Spada, Angelo De Milito et al. · JNCI Journal of the National Cancer Institute	16 Nov 2004	440
22	The multicentre south European study 'Helios'. II: Different sun exposure patterns in the aetiology of basal cell and squamous cell carcinomas of the skin Stefano Rosso, Roberto Zanetti, C. Martínez et al. · British Journal of Cancer Open access	Jun 1996	432
23	Randomized Trial of Fenretinide to Prevent Second Breast Malignancy in Women With Early Breast Cancer Umberto Veronesi et al. · JNCI Journal of the National Cancer Institute	3 Nov 1999	421
24	The effects of surgery on tumor growth: a century of investigations Romano Demicheli, Michael W Retsky, William J.M. Hrushesky et al. · Annals of Oncology Open access	13 Jun 2008	404
25	Clinical Findings with Implications for Genetic Testing in Families with Clustering of Colorectal Cancer Juul Wijnen et al. · New England Journal of Medicine Open access	20 Aug 1998	397
26	Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma Vincenzo Mazzaferro, Bassel F. El‐Rayes, Michele Droz Dit Busset et al. · British Journal of Cancer Open access	7 Nov 2018	385
27	Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland. Rosangela Donghi, Alberto Longoni, Silvana Pilotti et al. · Journal of Clinical Investigation Open access	Apr 1993	375
28	IDH1mutations at residue p.R132 (IDH1R132) occur frequently in high-grade gliomas but not in other solid tumors Fonnet E. Bleeker, Simona Lamba, Sieger Leenstra et al. · Human Mutation Open access	2009	372
29	DNA Vaccination Against Rat Her-2/Neu p185 More Effectively Inhibits Carcinogenesis Than Transplantable Carcinomas in Transgenic BALB/c Mice Stefania Rovero, Augusto Amici, Emma Di Carlo et al. · The Journal of Immunology Open access	Nov 2000	359
30	Arsenic Trioxide as an Inducer of Apoptosis and Loss of PML/RARα Protein in Acute Promyelocytic Leukemia Cells Wenlin Shao, Mirco Fanelli, Fabiana Fosca Ferrara et al. · JNCI Journal of the National Cancer Institute Open access	21 Jan 1998	357
31	Reprogramming of miRNA networks in cancer and leukemia Stefano Volinia et al. · Genome Research Open access	May 2010	353
32	Serum Sex Hormone Levels After Menopause and Subsequent Breast Cancer Franco Berrino, Paola C. Muti, Andrea Micheli et al. · JNCI Journal of the National Cancer Institute Open access	6 Mar 1996	338
33	Heat Shock Protein 70 Induced During Tumor Cell Killing Induces Th1 Cytokines and Targets Immature Dendritic Cell Precursors to Enhance Antigen Uptake Stephen M. Todryk, Alan A. Melcher, Nicola R. Hardwick et al. · The Journal of Immunology	Aug 1999	332
34	Position paper on vegetarian diets from the working group of the Italian Society of Human Nutrition Claudia Agnoli, Luciana Baroni, Ivano Bertini et al. · Nutrition Metabolism and Cardiovascular Diseases Open access	Nov 2017	320
35	Inhibition of the ABL Kinase Activity Blocks the Proliferation of BCR/ABL+Leukemic Cells and Induces Apoptosis Carlo B Gambacorti-Passerini, Philipp le Coutre, Luca Mologni et al. · Blood Cells Molecules and Diseases	Dec 1997	320
36	Antiangiogenic Potential of the Mammalian Target of Rapamycin Inhibitor Temsirolimus Donatella Del Bufalo, Ludovica Ciuffreda, Daniela Trisciuoglio et al. · Cancer Research	Jun 2006	317
37	The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets Enzo Médico, Mariangela Russo, Gabriele Picco et al. · Nature Communications Open access	30 Apr 2015	315
38	Cutting Edge: Bystander Apoptosis Triggers Dendritic Cell Maturation and Antigen-Presenting Function Patrizia Querini Rovere, Cristina Vallinoto, Attilio Bondanza et al. · The Journal of Immunology	Nov 1998	309
39	Opposite immune functions of GM-CSF administered as vaccine adjuvant in cancer patients Giorgio Parmiani, Chiara Castelli, Lorenzo Pilla et al. · Annals of Oncology Open access	21 Nov 2006	305
40	Recent advances on the role of tumor exosomes in immunosuppression and disease progression Paola Filipazzi, Maja Bürdek, Antonello Villa et al. · Seminars in Cancer Biology Open access	19 Feb 2012	297
41	Immunity to cancer: attack and escape in T lymphocyte–tumor cell interaction Licia Rivoltini, Matteo Giovanni Carrabba, Veronica Huber et al. · Immunological Reviews Review	Oct 2002	285
42	Genetics, Cytogenetics, and Epigenetics of Colorectal Cancer Lucia Migliore, Francesca Migheli, Roberto Spisni et al. · BioMed Research International Open access	2011	280
43	Histologic evaluation of necrosis in osteosarcoma induced by chemotherapy regional mapping of viable and nonviable tumor Piero Picci, Gaetano Bacci, Mario Campanacci et al. · Cancer Open access	Oct 1985	280
44	Survival of European adolescents and young adults diagnosed with cancer in 2000–07: population-based data from EUROCARE-5 Annalisa Trama, Laura Botta, Roberto Foschi et al. · The Lancet Oncology Open access	26 May 2016	274
45	HER2 as a Prognostic Factor in Breast Cancer Sylvie Ménard, Stefania Fortis, Fabio Castiglioni et al. · Oncology	2001	273
46	Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC) N. E. Allen et al. · Endocrine Related Cancer Open access	28 May 2008	272
47	First-in-Human Phase I Study of Fisogatinib (BLU-554) Validates Aberrant FGF19 Signaling as a Driver Event in Hepatocellular Carcinoma Richard D. Kim et al. · Cancer Discovery Open access	Oct 2019	270
48	Feed forward neural networks for the analysis of censored survival data: a partial logistic regression approach Elia Mario Biganzoli, Patrizia Boracchi, Luigi Mariani et al. · Statistics in Medicine	30 May 1998	270
49	Estrogen Metabolism and Risk of Breast Cancer: A Prospective Study of the 2:16α-Hydroxyestrone Ratio in Premenopausal and Postmenopausal Women Paola C. Muti, H. Leon Bradlow, Andrea Micheli et al. · Epidemiology	Nov 2000	266
50	Combined impact of healthy lifestyle factors on colorectal cancer: a large European cohort study Krasimira Aleksandrova et al. · BMC Medicine Open access	7 Oct 2014	264

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.